Terms: = Leukemia AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Prognosis
56 results:
1. GDF11 level and its effect on prognosis in patients with acute myeloid leukemia.
Aslan NA; Avcı E; Şenol H; Güler N
J Investig Med; 2024 Apr; 72(4):341-348. PubMed ID: 38415361
[TBL] [Abstract] [Full Text] [Related]
2. Quality and Quantity of Nucleic Acids Extracted from Formalin-Fixed Paraffin-Embedded Lymphoma Biopsies from Nigerian Archived Biopsy.
Uzoma IC; Taiwo IA; Ugwu NI; Durosinmi MA; Akinloye O
Niger J Clin Pract; 2023 Dec; 26(12):1854-1860. PubMed ID: 38158353
[TBL] [Abstract] [Full Text] [Related]
3. Cytokine levels in patients with non-M3 myeloid leukemia are key indicators of how well the disease responds to chemotherapy.
Hu R; Ling X; Yang T; Zhang J; Gu X; Li F; Chen H; Wen Y; Li Z; Zou Y; Du Y
Clin Exp Med; 2023 Dec; 23(8):4623-4632. PubMed ID: 37925379
[TBL] [Abstract] [Full Text] [Related]
4. AXL - a new player in resistance to her2 blockade.
Adam-Artigues A; Arenas EJ; Arribas J; Prat A; Cejalvo JM
Cancer Treat Rev; 2023 Dec; 121():102639. PubMed ID: 37864955
[TBL] [Abstract] [Full Text] [Related]
5. Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights.
Shibata T; Nohara S; Morikawa N; Shibao K; Ito S; Shibata R; Toh U; Nagafuji K; Fukami K; Fukumoto Y
Eur J Prev Cardiol; 2023 Dec; 30(18):1941-1949. PubMed ID: 37352112
[TBL] [Abstract] [Full Text] [Related]
6. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
[TBL] [Abstract] [Full Text] [Related]
7. Investigation of the function of the PI3-Kinase / AKT signaling pathway for leukemogenesis and therapy of acute childhood lymphoblastic leukemia (ALL).
Ehm P; Grottke A; Bettin B; Jücker M
Cell Signal; 2022 May; 93():110301. PubMed ID: 35259456
[TBL] [Abstract] [Full Text] [Related]
8. Changes in Ki-67 in Residual Tumor and Outcome of Primary Inflammatory Breast Cancer Treated With Trimodality Therapy.
Song Z; Li C; Zhou D; Liu J; Qian X; Zhang J
Clin Breast Cancer; 2022 Jul; 22(5):e655-e663. PubMed ID: 35248490
[TBL] [Abstract] [Full Text] [Related]
9. Risk factor for breast cancer development under exposure to bovine leukemia virus in Colombian women: A case-control study.
Olaya-Galán NN; Salas-Cárdenas SP; Rodriguez-Sarmiento JL; Ibáñez-Pinilla M; Monroy R; Corredor-Figueroa AP; Rubiano W; de la Peña J; Shen H; Buehring GC; Patarroyo MA; Gutierrez MF
PLoS One; 2021; 16(9):e0257492. PubMed ID: 34547016
[TBL] [Abstract] [Full Text] [Related]
10. [Analysis of Correlation between Interval Time of Chemotherapy and prognosis in Patients with Acute leukemia].
Zhang QY; Lyu XY; Wang YZ; Li ZJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):. PubMed ID: 34105461
[TBL] [Abstract] [Full Text] [Related]
11. Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future.
Li L; Zhu X; Qian Y; Yuan X; Ding Y; Hu D; He X; Wu Y
Front Immunol; 2020; 11():594271. PubMed ID: 33224149
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
[No Abstract] [Full Text] [Related]
13. Bispecific Antibodies for Triple Negative Breast Cancer.
Dees S; Ganesan R; Singh S; Grewal IS
Trends Cancer; 2021 Feb; 7(2):162-173. PubMed ID: 33041246
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive analysis the potential biomarkers for the high-risk of childhood acute myeloid leukemia based on a competing endogenous RNA network.
Zhang N; Chen Y; Shen Y; Lou S; Deng J
Blood Cells Mol Dis; 2019 Nov; 79():102352. PubMed ID: 31404908
[TBL] [Abstract] [Full Text] [Related]
15. Identification of MiR-125a as a Novel Plasma Diagnostic Biomarker for Chronic Lymphoblastic leukemia.
Ahmadvand M; Eskandari M; Khakpour G; Pashaiefar H; Manoochehrabadi S; Yaghmaie M; Montazer-Zohour M; Naghavi A
Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868841
[No Abstract] [Full Text] [Related]
16. Biomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer.
Koga F; Takemura K; Fukushima H
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223570
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics.
Khan M; Loree JM; Advani SM; Ning J; Li W; Pereira AAL; Lam M; Raghav K; Morris VK; Broaddus R; Maru D; Overman MJ; Kopetz S
Clin Colorectal Cancer; 2018 Dec; 17(4):e699-e709. PubMed ID: 30205948
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphoma.
Inoue Y; Fuji S; Tanosaki R; Inamoto Y; Tanaka T; Ito A; Okinaka K; Kurosawa S; Kim SW; Nakagama H; Fukuda T
Bone Marrow Transplant; 2018 Sep; 53(9):1105-1115. PubMed ID: 29523883
[TBL] [Abstract] [Full Text] [Related]
19. Pharmacologic measures in the prevention of left ventricular dysfunction associated with molecular-targeted therapies in the treatment of cancer patients.
Awada G; de Azambuja E; Awada A
Expert Opin Drug Metab Toxicol; 2017 Dec; 13(12):1205-1215. PubMed ID: 29088977
[TBL] [Abstract] [Full Text] [Related]
20. Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial.
Möbus V; Jackisch C; Lück HJ; du Bois A; Thomssen C; Kuhn W; Nitz U; Schneeweiss A; Huober J; Harbeck N; von Minckwitz G; Runnebaum IB; Hinke A; Konecny GE; Untch M; Kurbacher C;
Ann Oncol; 2018 Jan; 29(1):178-185. PubMed ID: 29069370
[TBL] [Abstract] [Full Text] [Related]
[Next]
